Effectiveness of ustekinumab dose escalation in Crohn's disease patients with insufficient response to standard-dose subcutaneous maintenance therapy. - Kopylov U; Hanzel J; Liefferinckx C; De Marco D; Imperatore N; Plevris N; Baston-Rey I; Harris RJ; Truyens M; Domislovic V; Vavricka S; Biemans V; et al. (Alimentary pharmacology & therapeutics, 2020)